Management of Antiphospholipid Antibody Syndrome with Elevated Prolactin Levels

Diagnostic Approach

The American College of Endocrinology recommends confirming hyperprolactinemia with repeat measurement, preferably in the morning while fasting, to exclude stress-induced or pulsatile elevation 1
For modestly elevated prolactin levels, the Endocrine Society considers serial measurements with samples taken 20-60 minutes apart using an indwelling cannula 2, 1
The American Association of Clinical Endocrinologists suggests ruling out common causes of hyperprolactinemia including medication effects, primary hypothyroidism, pregnancy, and stress 1, 3
Assess for macroprolactinemia in patients with mildly elevated prolactin levels, especially if asymptomatic, as recommended by the American College of Endocrinology 1, 3

The American College of Endocrinology recommends dopamine agonists as the first-line treatment for prolactinomas and hyperprolactinemia to reduce serum prolactin 1
Cabergoline is preferred over bromocriptine due to superior effectiveness and better tolerability, according to the Endocrine Society 1

Measure prolactin levels 1-3 months after initiating treatment and every 3-6 months until stabilized, as recommended by the American College of Endocrinology 3
For patients on standard doses of cabergoline (≤2 mg/week), perform echocardiographic surveillance every 6-12 months, according to the American Heart Association 3

Do not miss the "hook effect" - falsely low prolactin levels in large tumors due to assay saturation, as warned by the American College of Endocrinology 1, 3
Do not overlook macroprolactinemia - present in 10-40% of patients with hyperprolactinemia and may not require treatment, according to the Endocrine Society 1, 3
For women with APS and recurrent pregnancy loss, the American College of Rheumatology recommends prophylactic-dose heparin and aspirin 4